Endometrial Polyp and Its Clinico-Pathological Correlation
Abstract
Background: Endometrial polyps are localized overgrowths of the endometrial tissue, commonly seen in women presenting with abnormal uterine bleeding (AUB). Though generally benign, they may coexist with or mimic precancerous or malignant lesions, necessitating a clinico- pathological evaluation. Objective: To evaluate the clinical presentation and histopathological features of endometrial polyps, and to correlate these findings with non-polypoidal endometrial lesions to determine distinguishing features that can aid diagnosis and reduce unnecessary hospital admissions. Methods: A retrospective study was conducted on 38 cases over two years (2022–2024) in the Department of Pathology, Amrita Institute of Medical Sciences, Faridabad. Histopathological data and clinical profiles were collected for each case. Statistical analysis was conducted using parametric tests and ANOVA. All endometrial biopsies and hysterectomy specimens were included; malignancies and non-endometrial polyps were excluded. Results: Out of 38 cases, 4 (10.53%) were endometrial polyps and 34 (89.47%) were non-polypoidal lesions. The mean age of patients with polyps was 43.25 years, while for non-polyp cases it was 45.24 years, with no significant age-related difference. Polypoidal lesions presented primarily with AUB (75%) and proliferative endometrium (100%), with one showing simple hyperplasia without atypia. Non- polypoidal lesions exhibited a broader range of endometrial phases, including proliferative (73.53%) and secretory (26.47%) types, without any hyperplasia or malignancy. Conclusion: Endometrial polyps are most commonly seen in perimenopausal women with AUB and display distinct histological patterns, particularly proliferative changes. However, clinically and demographically, they are indistinguishable from non-polypoidal lesions. Accurate pathological diagnosis remains essential for guiding patient management, avoiding overtreatment, and reducing the financial burden on patients. How to cite this article:Gosai A, Vibbha I, Gandhi A. Endometrial Polyp
and Its Clinico-Pathological Correlation. Rec Adv
Path Lab Med. 2024;10(3&4):16-20. DOI: https://doi.org/10.24321/2454.8642.202408
References
Antunes Jr A, Costa-Paiva L, Arthuso M, Costa JV,
Pinto-Neto AM. Endometrial polyps in pre- and
postmenopausal women: factors associated with
malignancy. Maturitas. 2007;57(4):415-21. [PubMed]
[Google Scholar]
Mittal K, Schwartz PE. Endometrial polyps:
clinicopathologic aspects and oncogenic potential.
J Clin Oncol. 2010;28(8):e137–e138. doi:10.1200/
JCO.2009.26.2448.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Recent Advances in Pathology and Laboratory Medicine ( ISSN: 2454-8642 )

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
We, the undersigned, give an undertaking to the following effect with regard to our article entitled
“_______________________________________________________________________________________________________________________________________________________________________________
________________________________________________________________________________” submitted for publication in (Journal title)________________________________________________ _______________________________________________________Vol.________, Year _________:-
1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.
2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.
3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.
4. I/We hereby acknowledge ADRs conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.
5. I/We also agree to the authorship of the article in the following sequence:-
Authors' Names (in sequence) Signature of Authors
1. _____________________________________ _____________________________________
2. _____________________________________ _____________________________________
3. _____________________________________ _____________________________________
4. _____________________________________ _____________________________________
5. _____________________________________ _____________________________________
6. _____________________________________ _____________________________________
7. _____________________________________ _____________________________________
8. _____________________________________ _____________________________________
Important
(I). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/ country and whose whereabouts are not known, the senior author may sign on his/ her behalf taking the responsibility.
(ii). No addition/ deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.
(iii). If the authorship is contested at any stage, the article will be either returned or will not be
processed for publication till the issue is solved.